NPPA issued a notification regarding the

Dec 02, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on November 25, 2025, issued a notification regarding the computation of the Retail Price of Human normal immunoglobulin.

It has revised the ceiling price of Human Normal Immunoglobulin (16.5%) Solution for Infusion. Two qualifying brands—BHARGLOB and INTAGLOB—were considered for price fixation, representing more than 1% market share. After applying the average Price-to-Retailer (PTR), 16% retailer margin, and subsequent WPI-linked increments, the revised ceiling price is calculated at ₹478.57 per ml (excluding GST).

View Document 1